GenAssist, Inc.
PrivateLast Round
Grant
Aug 1, 2026
Total Funding Raised
$1.64M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GenAssist, Inc. operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Grant round in August 2026.
GenAssist, Inc. is a biotechnology company that develops regenerative biomaterials, including its flagship MyoMatrix™ scaffold, to restore skeletal muscle structure and function following traumatic injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenAssist, Inc. Comparables
Compare GenAssist, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sarcogenics | 86% | |
| Conexeu Sciences Inc. | 76% | |
| Spiderwort | 66% |
For institutional investors. Book with your work email.
GenAssist, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2026 | ||||
| SAFE | Apr 17, 2026 | ||||
| Grant | Oct 28, 2025 | ||||
| Grant | May 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenAssist, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arch Grants | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 34% MoM.
- Aug 1, 2026
$1.25M grant awarded by the National Science Foundation.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardOct 22, 2026
At the conference, GenAssist Inc. and CranioSense receive the People's Choice Award.
For institutional investors. Book with your work email.
GenAssist, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenAssist, Inc.'s valuation, stock price, and market status.
Is GenAssist, Inc. a public or private company?
GenAssist, Inc. is a private company.
What is the current stock price of GenAssist, Inc.?
GenAssist, Inc. is a private company, so its shares have no public market price. Caplight tracks GenAssist, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenAssist, Inc. worth (valuation)?
Valuation information for GenAssist, Inc. is not publicly available.
Can I buy GenAssist, Inc. stock?
GenAssist, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenAssist, Inc.'s last funding round?
GenAssist, Inc.'s most recent funding round was Grant on August 1, 2026.
Who are the main investors in GenAssist, Inc.?
Key investors in GenAssist, Inc. include Arch Grants, National Science Foundation.
Will GenAssist, Inc. IPO soon?
No public IPO plans have been announced for GenAssist, Inc..
How can I track GenAssist, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in GenAssist, Inc.'s shares on secondary markets.